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S. Joshi-Barve, I. Kirpich, M. C. Cave, L. S. Marsano, and C. J. McClain
This article reviews selected important mechanistic similarities and differences in alcoholic
steatohepatitis, nonalcoholic steatohepatitis, and toxicant-associated steatohepatitis.368 Functional and Structural Features of Cholangiocytes in Health and
Disease
L. Maroni, B. Haibo, D. Ray, T. Zhou, Y. Wan, F. Meng, M. Marzioni, and G. Alpini
Important pathophysiological changes occur in cholangiocytes in response to injury. These
will be addressed in the review, with particular emphasis on neuroendocrine factors and
morphogenic signaling pathways activated in reactive cholangiocytes.ORIGINAL RESEARCH
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Y. Avitzur, R. V. Stan, and A. M. Muise
This study describes a novel form of severe fatal Protein Losing Enteropathy caused by a
nonsense mutation in Plasmalemma Vesicle Associated Protein (PLVAP) gene resulting in loss
of PLVAP mRNA and protein expression of fenestrae diaphragms and compromised
endothelial barrier function.
See editorial, Sakamori R et al, on page 348
395 Modulation of Hepatic Protein Kinase Cb Expression in Metabolic
Adaptation to a Lithogenic Diet
W. Huang and K. D. Mehta
Examining the basic mechanisms by which lithogenic diet-induced hepatic protein kinase Cb
(PKCb) expression initiates signal transduction pathways to control cholesterol metabolism
reveals novel ileum and liver PKCb regulatory axes critical for ﬁne-tuning hepatic cholesterol
content and bile lithogenicity.
See editorial, Chiang JYL, on page 350
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S. Omenetti, M. Brogi, W. A. Goodman, C. M. Croniger, S. Eid, A. Y. Huang, G. Lafﬁ,
T. Roskams, F. Cominelli, M. Pinzani, and T. T. Pizarro
Ileitis-prone SAMP1/YitFc mice display concomitant immune-mediated liver inﬂammation,
which is driven by hyperactivated intrahepatic TH1 CD4
þ T effector cells. Locally impaired
hepatic immunosuppression rather than recruitment of gut-derived cells is likely responsible
for the heightened activation status of these cells.420 Substance P Mediates Proinﬂammatory Cytokine Release From
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A. Sideri, K. Bakirtzi, D. Q. Shih, H. W. Koon, P. Fleshner, R. Arsenescu, V. Arsenescu,
J. R. Turner, I. Karagiannides, and C. Pothoulakis
Preadipocytes in inﬂammatory bowel disease (IBD) have acquired, differential disease-
dependent characteristics that lead to changes in the release of inﬂammation-associated
mediators after substance P (SP) treatment; interleukin 17 (IL-17) is the most consistently
regulated mediator in isolated human mesenteric preadipocytes.
See editorial, Gewirtzl AT, on page 352
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via Induction of Regulatory T Cells
T. Weinhage, J. Däbritz, A. Brockhausen, T. Wirth, M. Brückner, M. Belz, D. Foell, and
G. Varga
Monocytes can mediate the clinical response of granulocyte macrophage colony-stimulating
factor (GM-CSF) in colitis. GM-CSF-activated monocytes express adenosine triphosphate–
converting enzymes (CD39/CD73) to generate adenosine which possibly induces regulatory
T cells. This mechanism of monocytes may control intestinal inﬂammation.
See editorial, Viennois E, on page 354
